Hepatitis C virus (HCV) infection is the most commonly reported bloodborne infection in the
United States, causing substantial morbidity and mortality and costing billions of dollars …

Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …

Background In phase 2 trials, the nucleotide polymerase inhibitor sofosbuvir was effective in
previously untreated patients with chronic hepatitis C virus (HCV) genotype 1, 2, or 3 …

Cancer is the leading cause of death among Hispanics/Latinos, who represent the largest
racial/ethnic minority group in the United States, accounting for 17.4%(55.4 million/318 …

Importance Hepatitis C virus (HCV) infects more than 185 million individuals worldwide.
Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler …

Hepatitis C virus (HCV) is an increasing cause of morbidity and mortality in the United
States. Many of the 2.7–3.9 million persons living with HCV infection are unaware they are …

The role of antiretroviral therapy (ART) in reducing or contributing to liver fibrosis in persons
with human immunodeficiency virus (HIV) is unclear. We evaluated participants in the …

Hepatitis C virus (HCV) infection is a leading cause of cirrhosis, hepatocellular carcinoma,
and liver transplantation. A better understanding of HCV disease progression and the …

Chronic homelessness is a highly complex social problem of national importance. The
problem has elicited a variety of societal and public policy responses over the years …

Background & Aims Although treatment of hepatitis C virus (HCV) infection has improved,
the prevalence of alcoholic liver disease (ALD) has been increasing, so we need an …